Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimes

Nat Biotechnol. 2022 Feb;40(2):167-169. doi: 10.1038/s41587-021-01204-y.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Books
  • Citrus sinensis*
  • Legislation, Drug
  • United States
  • United States Food and Drug Administration